Royce & Associates »

4d Molecular Therapeutics In shares owned by Royce & Associates

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Royce & Associates from 13F filings

Historical chart of Royce & Associates investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Royce & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Royce & Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $380k 19k 20.26
2021-12-31 $204k 9.3k 21.94